Thursday, November 9, 2023 NINE-MONTH TURNOVER UP +5.8% AND +12.8% AT CONSTANT SCOPE AND EXCHANGE RATES AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and structural parts for electric vehicles, has recorded, over the first 9 months of 2023,
Nigerian Lawyer Zannah Bukar Mustapha Receives Prestigious Global Citizen Award LONDON, Nov. 09, 2023 (GLOBE NEWSWIRE) — Internationally recognized humanitarian, philanthropist, and Founder of the Future Prowess Foundation School for orphans and less privileged children Zannah Bukar Mustapha has been named as the 2023 recipient of the Global Citizen Award, an annual tribute presented
Smart City Expo closes a record-braking 2023 edition BARCELONA, Spain, Nov. 09, 2023 (GLOBE NEWSWIRE) — The 2023 edition of Smart City Expo World Congress (SCEWC), the leading international summit on cities and smart urban solutions organized by Fira de Barcelona, contributed to open a new era of urban innovation after
London, Nov. 09, 2023 (GLOBE NEWSWIRE) — London, UK – November 9, 2023 – OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, will be presenting innovative research at the upcoming ISPOR Europe conference in Copenhagen, Denmark. OPEN Health experts will contribute to the event through workshops,
CALGARY, Alberta, Nov. 09, 2023 (GLOBE NEWSWIRE) — Canada’s 50 most investible cleantech ventures have been announced by Foresight Canada, the country’s largest cleantech ecosystem accelerator. The Foresight 50 features inspiring cleantech ventures across a range of industries and sectors that provide solutions to some of society’s most pressing issues including green housing,
With additional patient-centric data, compute power, and an exciting new focus for its Bayer collaboration, the company is accelerating the shift of biotech to techbio SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today